T1	Pharmacological_substance 10 21	Thalidomide
N1000 	Reference T1 MeSH:D013792	Thalidomide
T2	Disorder 22 32	neuropathy
N1 	Reference T2 UMLS:C0442874	neuropathy
T3	Pharmacological_substance 48 59	Thalidomide
N1001 	Reference T3 MeSH:D013792	Thalidomide
T4	Pharmacological_substance 175 186	thalidomide
N1002 	Reference T4 MeSH:D013792	thalidomide
T5	Disorder 336 346	Neuropathy
N2 	Reference T5 UMLS:C0442874	Neuropathy
T6	Pharmacological_substance 379 390	thalidomide
N1003 	Reference T6 MeSH:D013792	thalidomide
T7	Disorder 458 488	sensorimotor axonal neuropathy
N3 	Reference T7 UMLS:C0393907	sensorimotor axonal neuropathy
T9	Pharmacological_substance 532 543	thalidomide
N1004 	Reference T9 MeSH:D013792	thalidomide
T10	Disorder 548 572	myxopapillary ependymoma
N4 	Reference T10 UMLS:C0205769	myxopapillary ependymoma
T11	Disorder 574 589	Crohn's disease
N5 	Reference T11 UMLS:C0010346	Crohn's disease
T12	Pharmacological_substance 631 642	Thalidomide
N1005 	Reference T12 MeSH:D013792	Thalidomide
T13	Disorder 643 653	neuropathy
N6 	Reference T13 UMLS:C0442874	neuropathy
T14	Pharmacological_substance 810 821	thalidomide
N1006 	Reference T14 MeSH:D013792	thalidomide
T15	Disorder 907 941	progressive peripheral neuropathy.
N7 	Reference T15 UMLS:C0442874	progressive peripheral neuropathy.
T16	Subject 36 45	childhood
T18	Disorder 130 149	teratogenic effects
N8 	Reference T18 UMLS:C0232910	teratogenic effects
T19	Disorder 314 334	neoplastic disorders
N9 	Reference T19 UMLS:C1882062	neoplastic disorders
N10 	Reference T19 UMLS:C1882062	neoplastic disorders
T20	Disorder 296 309;325 334	rheumatologic disorders
N11 	Reference T20 UMLS:C0009326	rheumatologic disorders
T21	Disorder 283 294;325 334	immunologic disorders
N12 	Reference T21 UMLS:C0021053	immunologic disorders
T22	Disorder 269 282;325 334	dermatologic, disorders
N13 	Reference T22 UMLS:C0037274	dermatologic, disorders
T25	Subject 222 227	adult
T28	Subject 788 796	Children
T29	Disorder 594 629	recurrent giant aphthous ulceration
T31	Subject 492 517	children aged 10-15 years
T33	Disorder 679 696	proximal weakness
N14 	Reference T33 UMLS:C3714552	proximal weakness
T35	Manner_cue 352 363	significant
T24	Subject 232 242	paediatric
T38	Speculation_cue 701 704	may
T40	Disorder 889 903;919 940	presymptomatic peripheral neuropathy
T41	Speculation_cue 822 828	should
